TCM
Tekla Capital Management Portfolio holdings
AUM
$2.56B
This Quarter Return
+5.19%
1 Year Return
+18.15%
3 Year Return
+62.34%
5 Year Return
+140.22%
10 Year Return
+499.57%
AUM
$2.8B
AUM Growth
+$2.8B
(+3.6%)
Cap. Flow
-$10.2M
Cap. Flow
% of AUM
-0.37%
Top 10 Holdings %
Top 10 Hldgs %
45.4%
Holding
164
New
19
Increased
21
Reduced
19
Closed
12
Top Buys
| 1 |
Gilead Sciences
GILD
|
$22M |
| 2 |
Thermo Fisher Scientific
TMO
|
$15.1M |
| 3 |
Teva Pharmaceuticals
TEVA
|
$13M |
| 4 |
Johnson & Johnson
JNJ
|
$11M |
| 5 |
Edwards Lifesciences
EW
|
$10.6M |
Top Sells
| 1 |
iShares Biotechnology ETF
IBB
|
$23.6M |
| 2 |
PRTK
Paratek Pharmaceuticals, Inc.
PRTK
|
$12.8M |
| 3 |
Biogen
BIIB
|
$12.6M |
| 4 |
Amgen
AMGN
|
$12M |
| 5 |
Puma Biotechnology
PBYI
|
$11.6M |
Sector Composition
| 1 | Healthcare | 93.03% |
| 2 | Real Estate | 2.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Humana
HUM
$37.5B
| $30.4M | 1.09% |
124,781
| – | – |
|
27
Pfizer
PFE
$141B
| $28.9M | 1.03% |
810,087
| – | – |
|
28
Sarepta Therapeutics
SRPT
$1.98B
| $24.3M | 0.87% |
536,600
+25,000
| +5% | +$1.13M |
|
29
Cencora
COR
$57.2B
| $23.8M | 0.85% |
288,187
+33,300
| +13% | +$2.76M |
|
30
Centene
CNC
$14.8B
| $22.3M | 0.8% |
230,158
+37,558
| +20% | +$3.63M |
|
31
McKesson
MCK
$85.9B
| $21.9M | 0.78% |
142,800
| – | – |
|
32
Idexx Laboratories
IDXX
$50.7B
| $20.6M | 0.74% |
132,352
| – | – |
|
33
SPDR S&P Biotech ETF
XBI
$5.29B
| $19.6M | 0.7% |
226,460
| – | – |
|
34
Cigna
CI
$80.2B
| $18.7M | 0.67% |
100,002
+16,102
| +19% | +$3.01M |
|
|
NVRO
35
DELISTED
NEVRO CORP.
NVRO
| $17.7M | 0.63% |
194,621
| – | – |
|
|
PVLA
36
Palvella Therapeutics, Inc. Common Stock
PVLA
$592M
| $16.3M | 0.58% |
2,837,573
| – | – |
|
37
AstraZeneca
AZN
$255B
| $15M | 0.54% |
442,600
-108,000
| -20% | -$3.66M |
|
38
Omega Healthcare
OHI
$12.5B
| $14.6M | 0.52% |
458,616
| – | – |
|
39
GSK
GSK
$79.3B
| $14.6M | 0.52% |
359,000
| – | – |
|
40
Charles River Laboratories
CRL
$7.99B
| $13.7M | 0.49% |
127,100
| – | – |
|
41
Alnylam Pharmaceuticals
ALNY
$58.6B
| $13.5M | 0.48% |
114,966
| – | – |
|
42
Medical Properties Trust
MPW
$2.66B
| $13.2M | 0.47% |
1,007,717
| – | – |
|
43
Acadia Healthcare
ACHC
$2.15B
| $13M | 0.47% |
272,400
+41,200
| +18% | +$1.97M |
|
|
WELL.PRI
44
DELISTED
Welltower Inc.
WELL.PRI
| $12.7M | 0.45% |
200,000
| – | – |
|
|
DHC
45
Diversified Healthcare Trust
DHC
$903M
| $12.6M | 0.45% |
646,554
| – | – |
|
|
46
Puma Biotechnology
PBYI
$258M
| $12.6M | 0.45% |
105,495
-97,042
| -48% | -$11.6M |
|
|
SGEN
47
DELISTED
Seagen Inc. Common Stock
SGEN
| $12.2M | 0.44% |
223,700
| – | – |
|
48
Sabra Healthcare REIT
SBRA
$4.56B
| $12.1M | 0.43% |
550,990
| – | – |
|
49
Ventas
VTR
$30.7B
| $11.5M | 0.41% |
175,991
| – | – |
|
|
DERM
50
DELISTED
Dermira, Inc.
DERM
| $10.7M | 0.38% |
396,900
+10,000
| +3% | +$270K |
|